Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status

Benny Vittrup Jensen, Jakob V Schou, Mette Yilmaz, Helle H Johannesen, Kristin Skougaard, Dorte Linnemann, Estrid V Hogdall, Finn O Larsen, Julia S Johansen, Per Pfeiffer, Dorte L Nielsen

6 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science